State of the Art ReviewTissue Engineering

Cell and tissue engineering for liver disease

+ See all authors and affiliations

Science Translational Medicine  16 Jul 2014:
Vol. 6, Issue 245, pp. 245sr2
DOI: 10.1126/scitranslmed.3005975

You are currently viewing the abstract.

View Full Text

Abstract

Despite the tremendous hurdles presented by the complexity of the liver’s structure and function, advances in liver physiology, stem cell biology and reprogramming, and the engineering of tissues and devices are accelerating the development of cell-based therapies for treating liver disease and liver failure. This State of the Art Review discusses both the near- and long-term prospects for such cell-based therapies and the unique challenges for clinical translation.

View Full Text

Related Content